NO930505L - Nye azaindoler, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav - Google Patents
Nye azaindoler, fremgangsmaate for deres fremstilling og farmasoeytiske preparater deravInfo
- Publication number
- NO930505L NO930505L NO93930505A NO930505A NO930505L NO 930505 L NO930505 L NO 930505L NO 93930505 A NO93930505 A NO 93930505A NO 930505 A NO930505 A NO 930505A NO 930505 L NO930505 L NO 930505L
- Authority
- NO
- Norway
- Prior art keywords
- cycloalkyl
- alkyl
- optionally substituted
- preparation
- phenyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000002475 indoles Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- -1 R5 and R6 denote H Chemical group 0.000 abstract 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000006350 alkyl thio alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 230000000055 hyoplipidemic effect Effects 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Abstract
Nye forbindelser som har den generelle formel: hvor en av gruppene X1 til X4 er nitrogen og de andre er et CH-radikal, R1 og R2 er H, halogen, alkyl, hydroksymetyl, alkyloksymetyl, dialkylaminoalkyl, dialkylaminoalkyloksymetyl, karboksyl, metylkarboksylat, piperidin, alkenyl, cykloalkyl, cykloalkenyl, alkyltio, benzyl, fenyl, tiofen eller pyridin som eventuelt er substituerte, R2 og R4 er H, halogen, alkyl, cykloalkyl, alkoksy eller alkyltio, R5 og R6 er K, alkyl, alkenyl, cykloalkyl, cykloalkenyl, alkoksyalkyl eller alkyltioalkyl, eller danner sammen alkylen- eller alkylenoksyalkylenkjeder, R, er H, alkyl eller cykloalkyl, et av radikalene R5 - R7 kan også være eventuelt substituert fenyl eller benzyl, Reer H, alkyl, cykloalkyl eller eventuelt substituert fenyl eller benzyl, R, er eventuelt substituert fenyl, naftyl eller en heterosyklisk forbindelse, så vel som deres tautomere former. Fremgangsmåter for deres fremstilling er også beskrevet. Forbindelsene har terapeutisk anvendelse.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9201701A FR2687402B1 (fr) | 1992-02-14 | 1992-02-14 | Nouveaux azaindoles, procedes de preparation et medicaments les contenant. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO930505D0 NO930505D0 (no) | 1993-02-12 |
| NO930505L true NO930505L (no) | 1993-08-16 |
Family
ID=9426663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO93930505A NO930505L (no) | 1992-02-14 | 1993-02-12 | Nye azaindoler, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5338849A (no) |
| EP (1) | EP0557171B1 (no) |
| JP (1) | JPH061788A (no) |
| KR (1) | KR930017905A (no) |
| AT (1) | ATE125257T1 (no) |
| AU (1) | AU658475B2 (no) |
| CA (1) | CA2089470A1 (no) |
| CZ (1) | CZ16893A3 (no) |
| DE (1) | DE69300268T2 (no) |
| DK (1) | DK0557171T3 (no) |
| ES (1) | ES2076827T3 (no) |
| FR (1) | FR2687402B1 (no) |
| GR (1) | GR3017614T3 (no) |
| HR (1) | HRP930180A2 (no) |
| HU (1) | HUT64067A (no) |
| IL (1) | IL104573A0 (no) |
| LT (1) | LT3065B (no) |
| LV (1) | LV10453B (no) |
| MA (1) | MA22797A1 (no) |
| MX (1) | MX9300745A (no) |
| NO (1) | NO930505L (no) |
| NZ (1) | NZ245869A (no) |
| OA (1) | OA09775A (no) |
| SI (1) | SI9300076A (no) |
| SK (1) | SK9093A3 (no) |
| TN (1) | TNSN93016A1 (no) |
| ZA (1) | ZA93844B (no) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9226855D0 (en) * | 1992-12-23 | 1993-02-17 | Erba Carlo Spa | Vinylene-azaindole derivatives and process for their preparation |
| US5547966A (en) * | 1993-10-07 | 1996-08-20 | Bristol-Myers Squibb Company | Aryl urea and related compounds |
| DE69728688T2 (de) | 1996-11-19 | 2004-08-19 | Amgen Inc., Thousand Oaks | Aryl und heteroaryl substituierte kondensierte pyrrole als entzündunghemmende mittel |
| CA2306870A1 (en) | 1997-10-20 | 1999-04-29 | David Michael Goldstein | Bicyclic kinase inhibitors |
| WO1999031075A1 (en) * | 1997-12-16 | 1999-06-24 | Warner-Lambert Company | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
| EP1990343B1 (en) | 1999-12-24 | 2012-04-04 | Aventis Pharma Limited | Azaindoles |
| GB0115109D0 (en) * | 2001-06-21 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
| CN1625555A (zh) * | 2002-02-01 | 2005-06-08 | 阿斯特拉曾尼卡有限公司 | 喹唑啉化合物 |
| GB0207637D0 (en) * | 2002-04-02 | 2002-05-15 | Karobio Ab | Novel compound |
| SE0301372D0 (sv) * | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Novel compounds |
| PL1696920T3 (pl) * | 2003-12-19 | 2015-03-31 | Plexxikon Inc | Związki i sposoby opracowywania modulatorów Ret |
| US20070066641A1 (en) * | 2003-12-19 | 2007-03-22 | Prabha Ibrahim | Compounds and methods for development of RET modulators |
| US7507826B2 (en) | 2004-03-30 | 2009-03-24 | Vertex Pharmaceuticals Incorporated | Azaindoles useful as inhibitors of JAK and other protein kinases |
| JP2008503473A (ja) * | 2004-06-17 | 2008-02-07 | プレキシコン，インコーポレーテッド | Ｃ−ｋｉｔ活性を調節する化合物 |
| US7498342B2 (en) * | 2004-06-17 | 2009-03-03 | Plexxikon, Inc. | Compounds modulating c-kit activity |
| EP2264033A1 (en) | 2004-07-27 | 2010-12-22 | SGX Pharmaceuticals, Inc. | 3,5-DIPHENYL-SUBSTITUTED PYRROLO[2,3b]PYRIDINES USEFUL AS KINASE INHIBITORS |
| BRPI0513899A (pt) * | 2004-07-27 | 2008-05-20 | Sgx Pharmaceuticals Inc | moduladores de cinase heterocìclica de anel fundido |
| US7626021B2 (en) * | 2004-07-27 | 2009-12-01 | Sgx Pharmaceuticals, Inc. | Fused ring heterocycle kinase modulators |
| US7361764B2 (en) | 2004-07-27 | 2008-04-22 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
| EP1787991B2 (en) * | 2004-07-28 | 2020-06-24 | Takeda Pharmaceutical Company Limited | PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE |
| US20060183758A1 (en) * | 2005-02-17 | 2006-08-17 | Cb Research And Development, Inc. | Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans |
| CA2608733A1 (en) * | 2005-05-17 | 2007-02-01 | Plexxikon, Inc. | Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors |
| DK2395004T3 (en) * | 2005-06-22 | 2016-03-21 | Plexxikon Inc | Pyrrolo [2,3-b] pyridine derivatives as protein kinase inhibitors |
| TW201412738A (zh) | 2006-01-17 | 2014-04-01 | Vertex Pharma | 適合作為傑納斯激酶（ｊａｎｕｓ ｋｉｎａｓｅ）抑制劑之氮雜吲哚 |
| WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
| WO2008079909A1 (en) * | 2006-12-21 | 2008-07-03 | Plexxikon, Inc. | Pyrrolo [2,3-b] pyridines as kinase modulators |
| NZ577798A (en) | 2006-12-21 | 2012-04-27 | Vertex Pharma | 5-cyano-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| PE20081581A1 (es) * | 2006-12-21 | 2008-11-12 | Plexxikon Inc | COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA |
| WO2008080015A2 (en) | 2006-12-21 | 2008-07-03 | Plexxikon, Inc. | Compounds and methods for kinase modulation, and indications therefor |
| US20100190777A1 (en) | 2007-07-17 | 2010-07-29 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| FR2946342B1 (fr) | 2009-06-05 | 2011-06-24 | Galderma Res & Dev | Nouveaux derives de dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant. |
| FR2946345B1 (fr) | 2009-06-05 | 2011-05-20 | Galderma Res & Dev | Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant. |
| FR2946346B1 (fr) | 2009-06-05 | 2011-05-20 | Galderma Res & Dev | Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant. |
| FR2946340B1 (fr) | 2009-06-05 | 2011-06-24 | Galderma Res & Dev | Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant. |
| HUE027598T2 (en) * | 2009-04-03 | 2016-10-28 | Hoffmann La Roche | Propane-1-sulfonic acid {3- [5- (4-chlorophenyl) -1H-pyrrolo [2,3-B] pyridine-3-carbonyl] -2,4-difluorophenyl} amide compositions and their uses |
| DK2442809T3 (en) | 2009-06-17 | 2016-12-19 | Vertex Pharma | Inhibitors of the replication of influenza virus |
| US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
| ES2633317T3 (es) | 2009-11-06 | 2017-09-20 | Plexxikon, Inc. | Compuestos y métodos para la modulación de quinasas, e indicaciones para ello |
| JP5810157B2 (ja) * | 2010-07-09 | 2015-11-11 | ザ・ウォルター・アンド・エリザ・ホール・インスティテュート・オブ・メディカル・リサーチ | プロテインキナーゼ阻害剤および処置の方法 |
| AU2011343642A1 (en) | 2010-12-16 | 2013-05-02 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| MA34948B1 (fr) | 2011-02-07 | 2014-03-01 | Plexxikon Inc | Composes et procedes de modulation de kinase, et leurs indications |
| TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
| RS57541B1 (sr) | 2013-11-13 | 2018-10-31 | Vertex Pharma | Postupci za pripremu inhibitora replikacije virusa gripa |
| EP3068776B1 (en) | 2013-11-13 | 2019-05-29 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| JP6704416B2 (ja) | 2015-05-13 | 2020-06-03 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | インフルエンザウイルスの複製の阻害剤を調製する方法 |
| MA42422A (fr) | 2015-05-13 | 2018-05-23 | Vertex Pharma | Inhibiteurs de la réplication des virus de la grippe |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1261179A (fr) * | 1959-02-04 | 1961-05-19 | Chimiotherapie Lab Franc | 12-aza déserpidine et son procédé de préparation |
| US3354174A (en) * | 1964-02-19 | 1967-11-21 | Sterling Drug Inc | 1-and 2-benzimidazolyl-lower-alkylamidoximes, amidines-, and guanidines |
| IL83821A0 (en) * | 1986-09-10 | 1988-02-29 | Sandoz Ag | Azaindole and indolizine derivatives,their production and pharmaceutical compositions containing them |
| EP0279263B1 (en) * | 1987-02-10 | 1993-08-04 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| US5153226A (en) * | 1989-08-31 | 1992-10-06 | Warner-Lambert Company | Acat inhibitors for treating hypocholesterolemia |
| WO1991004027A1 (en) * | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| DE4022414A1 (de) * | 1990-07-13 | 1992-01-16 | Bayer Ag | Substituierte pyrrolo-pyridine |
| FR2674522B1 (fr) * | 1991-03-26 | 1993-07-16 | Lipha | Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant. |
-
1992
- 1992-02-14 FR FR9201701A patent/FR2687402B1/fr not_active Expired - Fee Related
-
1993
- 1993-02-01 IL IL104573A patent/IL104573A0/xx unknown
- 1993-02-04 US US08/013,427 patent/US5338849A/en not_active Expired - Fee Related
- 1993-02-08 ZA ZA93844A patent/ZA93844B/xx unknown
- 1993-02-09 NZ NZ245869A patent/NZ245869A/en unknown
- 1993-02-10 CZ CZ93168A patent/CZ16893A3/cs unknown
- 1993-02-10 OA OA60340A patent/OA09775A/fr unknown
- 1993-02-11 MX MX9300745A patent/MX9300745A/es unknown
- 1993-02-12 TN TNTNSN93016A patent/TNSN93016A1/fr unknown
- 1993-02-12 AU AU33005/93A patent/AU658475B2/en not_active Ceased
- 1993-02-12 CA CA002089470A patent/CA2089470A1/en not_active Abandoned
- 1993-02-12 EP EP93400366A patent/EP0557171B1/fr not_active Expired - Lifetime
- 1993-02-12 HU HU9300372A patent/HUT64067A/hu unknown
- 1993-02-12 AT AT93400366T patent/ATE125257T1/de not_active IP Right Cessation
- 1993-02-12 DE DE69300268T patent/DE69300268T2/de not_active Expired - Fee Related
- 1993-02-12 DK DK93400366.6T patent/DK0557171T3/da active
- 1993-02-12 JP JP5023965A patent/JPH061788A/ja active Pending
- 1993-02-12 MA MA23089A patent/MA22797A1/fr unknown
- 1993-02-12 SI SI19939300076A patent/SI9300076A/sl unknown
- 1993-02-12 SK SK9093A patent/SK9093A3/sk unknown
- 1993-02-12 NO NO93930505A patent/NO930505L/no unknown
- 1993-02-12 HR HR930180A patent/HRP930180A2/hr not_active Application Discontinuation
- 1993-02-12 ES ES93400366T patent/ES2076827T3/es not_active Expired - Lifetime
- 1993-02-12 LT LTIP339A patent/LT3065B/lt not_active IP Right Cessation
- 1993-02-12 LV LVP-93-119A patent/LV10453B/en unknown
- 1993-02-13 KR KR1019930001980A patent/KR930017905A/ko not_active Withdrawn
-
1995
- 1995-10-04 GR GR950402727T patent/GR3017614T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LV10453A (lv) | 1995-02-20 |
| ZA93844B (en) | 1994-08-08 |
| LT3065B (en) | 1994-10-25 |
| HU9300372D0 (en) | 1993-04-28 |
| NZ245869A (en) | 1995-05-26 |
| MA22797A1 (fr) | 1993-10-01 |
| DK0557171T3 (da) | 1995-12-04 |
| SK9093A3 (en) | 1993-09-08 |
| HUT64067A (en) | 1993-11-29 |
| TNSN93016A1 (fr) | 1994-03-17 |
| CZ16893A3 (en) | 1993-12-15 |
| MX9300745A (es) | 1993-09-01 |
| US5338849A (en) | 1994-08-16 |
| CA2089470A1 (en) | 1993-08-15 |
| OA09775A (fr) | 1993-11-30 |
| DE69300268D1 (de) | 1995-08-24 |
| NO930505D0 (no) | 1993-02-12 |
| KR930017905A (ko) | 1993-09-20 |
| JPH061788A (ja) | 1994-01-11 |
| FR2687402A1 (fr) | 1993-08-20 |
| EP0557171A1 (fr) | 1993-08-25 |
| SI9300076A (en) | 1993-09-30 |
| LTIP339A (en) | 1994-06-15 |
| IL104573A0 (en) | 1993-06-10 |
| AU3300593A (en) | 1993-08-19 |
| ATE125257T1 (de) | 1995-08-15 |
| LV10453B (en) | 1995-10-20 |
| EP0557171B1 (fr) | 1995-07-19 |
| HRP930180A2 (en) | 1995-10-31 |
| ES2076827T3 (es) | 1995-11-01 |
| DE69300268T2 (de) | 1996-04-04 |
| FR2687402B1 (fr) | 1995-06-30 |
| GR3017614T3 (en) | 1996-01-31 |
| AU658475B2 (en) | 1995-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO930505D0 (no) | Nye azaindoler, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav | |
| DE69130683D1 (de) | PYRAZOLO[1,5-a]PYRIMIDINDERIVATE UND SIE ENTHALTENDE ANTIINFLAMMATORISCHE MITTEL | |
| DE3881472D1 (de) | Heterocyclische verbindungen mit therapeutischer wirkung. | |
| ATE221064T1 (de) | Cyclische amidderivate als neurokinin a antagonisten | |
| ATE185344T1 (de) | Piperidinderivate von benzimidazole als antihistaminische und antiallergische mittel | |
| FI854768A0 (fi) | Bensoxazol- och bensotiazolaminderivat. | |
| ATE148464T1 (de) | Substituierte indole als anti-aids pharmaceutische zubereitungen | |
| ATE101612T1 (de) | Serotonin-antagonisten, ihre herstellung und sie enthaltende arzneimittel. | |
| ES2129483T3 (es) | Derivados de indol-7-carboxamida como analgesicos. | |
| ATE87206T1 (de) | Virusinhibierende heterocyclische verbindungen. | |
| SE8305217D0 (sv) | Karbapenem-antibiotika | |
| PL352172A1 (en) | Derivatives of n-alkoxyalkylo-n,n-dialkyloamine or salts thereof and the agents containing these compounds used in treatment of neurodegenerative diseases | |
| ATE201208T1 (de) | Ellipticinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen | |
| ATE243219T1 (de) | 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin |